Literature DB >> 20800680

Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.

Brigitte Stark1, Georg Pabst, Ruth Prassl.   

Abstract

Liposomes are widely investigated for their use as drug delivery systems, where they have to meet strict stability criteria. Hence, it is of common interest to establish appropriate storage conditions to improve the shelf life of liposomes. In general, long-term stability can be achieved by freezing as well as freeze-drying, and different carbohydrates or polyalcohols, such as mannitol or glycerol are considered as cryoprotective agents to inhibit liposomal fusion or degradation during freezing procedures. Here, we determined the impact of different cryoprotectants on physicochemical parameters of sterically stabilized PEGylated liposomes, which become increasingly important for pharmaceutical applications. We investigated particle stability in terms of size, lamellarity and thickness of the lipid bilayer using photon correlation spectroscopy and small angle X-ray scattering. Besides, we evaluated the impact of cryoprotectants on the thermal lipid phase behavior of either frozen/thawn or lyophilised/rehydrated PEGylated liposome formulations by differential scanning calorimetry. Optimal results for the preservation of the average size of the extruded unilamellar liposomes during freezing were achieved using a mixture of glycerol and carbohydrate concentrations of about 1% (w/v), irrespective of the carbohydrate used. We found no significant changes in the bilayer organisation, and the transition behavior of lipids was almost uneffected by freezing. In case of freeze-drying, similar carbohydrate concentrations as used for freezing were sufficient to maintain the size of PEGylated liposomes after reconstitution of the dried lyophilised cakes, but our small angle X-ray scattering data provide strong evidence that the lyophilisation/rehydration process affects lipid membrane reorganisation on a molecular level such that a swelling of the bilayer might occur. These internal structural changes, which are not detected by standard particle size analysis, might well influence drug release profiles and the pharmacological performance of a liposomal drug delivery system.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800680     DOI: 10.1016/j.ejps.2010.08.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  29 in total

Review 1.  Use of X-ray scattering to aid the design and delivery of membrane-active drugs.

Authors:  G Pabst; D Zweytick; R Prassl; K Lohner
Journal:  Eur Biophys J       Date:  2012-06-02       Impact factor: 1.733

2.  Fluorescence-quenching of a liposomal-encapsulated near-infrared fluorophore as a tool for in vivo optical imaging.

Authors:  Felista L Tansi; Ronny Rüger; Markus Rabenhold; Frank Steiniger; Alfred Fahr; Ingrid Hilger
Journal:  J Vis Exp       Date:  2015-01-05       Impact factor: 1.355

3.  Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.

Authors:  Hong Zheng; Yun Hu; Wei Huang; Sabina de Villiers; Paul Pentel; Jianfei Zhang; Harry Dorn; Marion Ehrich; Chenming Zhang
Journal:  J Biomed Nanotechnol       Date:  2015-12       Impact factor: 4.099

4.  Radio Frequency-Activated Nanoliposomes for Controlled Combination Drug Delivery.

Authors:  Swapnil A Malekar; Ashish L Sarode; Alvin C Bach; Arijit Bose; Geoffrey Bothun; David R Worthen
Journal:  AAPS PharmSciTech       Date:  2015-04-22       Impact factor: 3.246

5.  Reconstitutable charged polymeric (PLGA)(2)-b-PEI micelles for gene therapeutics delivery.

Authors:  Deepa Mishra; Han Chang Kang; You Han Bae
Journal:  Biomaterials       Date:  2011-02-26       Impact factor: 12.479

6.  Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.

Authors:  Juan J Carreras; Willian E Tapia-Ramirez; Adrian Sala; Antonio J Guillot; Teresa M Garrigues; Ana Melero
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 7.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

8.  Long-term storage of lyophilized liposomal formulations.

Authors:  Nicole M Payton; Michael F Wempe; Yemin Xu; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2014-10-10       Impact factor: 3.534

Review 9.  Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application.

Authors:  Domenico Lombardo; Mikhail A Kiselev
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

10.  Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)2 Containing Liposomes for the Treatment of Neuroblastoma.

Authors:  Friederike Hartwig; Monika Köll-Weber; Regine Süss
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.